Pre-treatment with curcumin, a component of the spice turmeric, makes ovarian cancer cells more vulnerable to chemotherapy and radiotherapy. Researchers found that delivering the curcumin via very small (less than 100nm) nanoparticles enhanced the sensitizing effect.